[1]
Kivipelto M, Maungialasche F. Dementia research in 2020: Moving forward despide the COVID-19 pandemic. Lancet Neurol 2021; 20(1): 3-5.
[2]
AlzForum Begone 2020: Despite COVID, Alzheimer's research advanced 2021. Available from: https://www.alzforum.org/news/research-news/begone-2020-despite-covid-alzheimers-research-advanced
[3]
Alzheimer’s Association Congressional leaders advance $300 million Alzheimer's research funding, improving HOPE for Alzheimer's act and renew investment in Alzheimer's public health in omnibus bill: Alzheimer's Association; 2020. Available from: https://www.alz.org/news/2020/congressional-leaders-advance-300-million alzheime#:~:text=Today's%20omnibus%20includes%20a%20%24300,880%2FH.R.
[4]
Quote Investigator. I have gotten a lot of results! I know several thousand things that won't work: Quote Investigator 2012. Available from: https://quoteinvestigator.com/2012/07/31/edison-lot-results/
[5]
AlzForum. Of four Aβ antibodies, only aducanumab stems tide of toxic oligomers: AlzForum 2020. Available from: https://www. alzforum.org/news/research-news/four-av-antibodies-only-aducanumabstems-tide-toxic-oligomers
[6]
Beasley D Lilly. says Alzheimer's drug slows clinical decline in midstage trial: Reuters; 2020. Available from: https://www.reuters. com/article/us-elililly-alzheimers/lilly-says-alzheimers-drug-slowsclinical-decline-in-mid-stage-trial-idUSKBN29G161
[7]
Lahiri DK. There is no Failure, Only discovery-the year ahead for CARving new paths. Curr Alzheimer Res 2020; 17(1): 1-2.
[8]
Wu S. Inhibition of store-operated calcium entry in Alzheimer’s disease and the associated mechanisms. Curr Alzheimer Res 2020. Curr Alzheimer Res 2020; 17(12): 1055-6.
[9]
Chaudhuri JR, Mridula KR, Rthnakishore C, et al. Association serum S100β protein in Alzheimer’s disease: A case control study from south India. Curr Alzheimer Res 2020; 17(12): 1095-101.
[10]
Manca R, Venneri A. A comparison of neurocognitive decline in older adults in same sex and opposite sex relationships. Curr Alzheimer Res 2020; 17(12): 1102-14.
[11]
Tomoto T, Sugawara J, Tarumi T, et al. Carotid areterial striffness and cerebral blood flow in amnestic mild cognitive impairment. Curr Alzheimer Res 2020; 17(12): 1115-25.
[12]
Ataka T, Kuimura N, Mizukami T, Uchida H, Matsubara E. Association of cerebrospinal fluid adiponectin levels with cerebral glucose metabolism in mild cognitive impairment: A pilot study. Curr Alzheimer Res 2020; 17(12): 1126-32.
[13]
Floden AM, Sohrabia M, Nookala S, Coob JJ, Combs CK. Salivary Aβ secretion and altered oral microbiome in mouse models of AD. Curr Alzheimer Res 2020; 17(12): 1133-44.
Related Books
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research-Dementia
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Article Metrics
25
1